NOT KNOWN DETAILS ABOUT MBL77

mutations and sophisticated kar yotype. It follows a linear evolution through the CLL clone from the recurrent acquisition of CDKN2AGenetic susceptibility mechanisms. Most susceptibility loci map to non-coding regions in the genome, are primarily situated in Lively promoters or enhancers, and modify the binding web sites of quite a few transcriptio